Article
The Lancet Diabetes and Endocrinology  (2014)

Effects of basal insulin glargine and omega-3 fatty acid on cognitive decline and probable cognitive impairment in people with dysglycaemia=> a substudy of the ORIGIN trial

Cukierman-Yaffe, T; Bosch J., Díaz R; Dyal, L; Hancu, N; Hildebrandt P., Lanas F.; Lewis, BS; Marre M., Yale; JF, Yusuf S.; Gerstein, HC